Jacobs Levy Equity Management Portfolio holdings
AUM
$25.5B
1-Year Return
20.81%
This Quarter Return
+1.57%
1 Year Return
+20.81%
3 Year Return
+97.14%
5 Year Return
+210.43%
10 Year Return
+444.59%
AUM
$24.2B
AUM Growth
+$1.8B
(+8.1%)
Cap. Flow
+$1.83B
Cap. Flow
% of AUM
7.57%
Top 10 Holdings %
Top 10 Hldgs %
25.17%
Holding
1,081
New
153
Increased
475
Reduced
286
Closed
135
Top Buys
| 1 |
Constellation Energy
CEG
|
$193M |
| 2 |
Amphenol
APH
|
$153M |
| 3 |
JB Hunt Transport Services
JBHT
|
$141M |
| 4 |
Meta Platforms (Facebook)
META
|
$127M |
| 5 |
Intuit
INTU
|
$127M |
Top Sells
| 1 |
Incyte
INCY
|
$143M |
| 2 |
Apple
AAPL
|
$117M |
| 3 |
NVIDIA
NVDA
|
$116M |
| 4 |
Mastercard
MA
|
$109M |
| 5 |
HP
HPQ
|
$99M |
Sector Composition
| 1 | Technology | 31.52% |
| 2 | Financials | 13.67% |
| 3 | Consumer Discretionary | 12.86% |
| 4 | Industrials | 10.88% |
| 5 | Healthcare | 10.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
601
Remitly
RELY
$4.02B
| $1.95M | 0.01% |
161,029
-71,085
| -31% | -$862K |
|
602
Charles Schwab
SCHW
$167B
| $1.94M | 0.01% |
26,366
-1,266,970
| -98% | -$93.4M |
|
603
Kearny Financial
KRNY
$415M
| $1.94M | 0.01% |
315,135
+234,917
| +293% | +$1.44M |
|
604
Grand Canyon Education
LOPE
$5.74B
| $1.93M | 0.01% |
13,799
+2,723
| +25% | +$381K |
|
605
Superior Group of Companies
SGC
$195M
| $1.92M | 0.01% |
101,782
+33,479
| +49% | +$633K |
|
606
CAVA Group
CAVA
$7.73B
| $1.92M | 0.01% |
+20,678
| New | +$1.92M |
|
607
Entrada Therapeutics
TRDA
$201M
| $1.91M | 0.01% |
+134,244
| New | +$1.91M |
|
608
Olo Inc
OLO
$1.74B
| $1.91M | 0.01% |
+431,422
| New | +$1.91M |
|
609
Avis
CAR
$5.5B
| $1.9M | 0.01% |
18,214
+6,747
| +59% | +$705K |
|
610
Matrix Service
MTRX
$403M
| $1.89M | 0.01% |
190,691
+21,084
| +12% | +$209K |
|
611
Conduent
CNDT
$447M
| $1.88M | 0.01% |
577,380
-186,536
| -24% | -$608K |
|
612
FibroGen
FGEN
$48.9M
| $1.88M | 0.01% |
84,196
-4,108
| -5% | -$91.6K |
|
613
Atea Pharmaceuticals
AVIR
$267M
| $1.87M | 0.01% |
564,898
-108,086
| -16% | -$358K |
|
614
Arlo Technologies
ARLO
$1.89B
| $1.87M | 0.01% |
+143,238
| New | +$1.87M |
|
615
Eastern Bankshares
EBC
$3.44B
| $1.85M | 0.01% |
132,611
-97,849
| -42% | -$1.37M |
|
616
CytomX Therapeutics
CTMX
$376M
| $1.84M | 0.01% |
1,507,717
+977,782
| +185% | +$1.19M |
|
617
Wave Life Sciences
WVE
$1.32B
| $1.83M | 0.01% |
366,601
+124,741
| +52% | +$622K |
|
618
Sterling Infrastructure
STRL
$8.7B
| $1.83M | 0.01% |
15,433
| – | – |
|
619
First Financial Corporation Common Stock
THFF
$695M
| $1.83M | 0.01% |
49,488
-13,789
| -22% | -$509K |
|
620
Amneal Pharmaceuticals
AMRX
$3.02B
| $1.82M | 0.01% |
287,260
-57,988
| -17% | -$368K |
|
621
Palo Alto Networks
PANW
$130B
| $1.81M | 0.01% |
+10,670
| New | +$1.81M |
|
622
Y-mAbs Therapeutics
YMAB
$390M
| $1.81M | 0.01% |
149,681
-4,335
| -3% | -$52.4K |
|
623
Regenxbio
RGNX
$490M
| $1.78M | 0.01% |
152,437
-139,904
| -48% | -$1.64M |
|
624
MacroGenics
MGNX
$126M
| $1.78M | 0.01% |
418,890
+270,872
| +183% | +$1.15M |
|
625
Ooma
OOMA
$346M
| $1.77M | 0.01% |
178,315
+52,291
| +41% | +$519K |
|